A supply of the Transdermal Autolytic Tuberculin, developed last year by Dr. H. J. Corper, director of the research department of the National Jewish Hospital at Denver, is on its way to the French Government, it was announced today at the hospital’s New York Office.
The request for this material, which makes possible speedier and simpler methods of detecting tuberculosis than those currently in general use, was made by the French Embassy in Washington on behalf of the Committee on Public Health and Social Assistance of the Republic of France.
Reporting the stories that define our era. When history unfolds in real-time, the Jewish world turns to JTA. Your support ensures we can document the complexities of war and the resilience of Jewish communities with integrity.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
